Andrew Chow

8PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer.

Hirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi

|Mar 20, 2024
Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.

Anton Dobrin, Pieter L Lindenbergh, Yuzhe Shi

|Aug 02, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers.

Alvaro Quintanal-Villalonga, Vidushi Durani, Amin Sabet

|Jul 20, 2023
Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector.

Nicholas Ceglia, Zachary Sethna, Samuel S Freeman

|Apr 06, 2023
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer.

Arvind Ravi, Matthew D Hellmann, Monica B Arniella

|Oct 10, 2022
Clinical implications of T cell exhaustion for cancer immunotherapy.

Andrew Chow, Karlo Perica, Christopher A Klebanoff

Pageof 2